Literature DB >> 29237087

Type, Frequency, and Spatial Distribution of Immune Cell Infiltrates in CNS Germinomas: Evidence for Inflammatory and Immunosuppressive Mechanisms.

Pia Zapka1, Evelyn Dörner1, Verena Dreschmann1, Noriaki Sakamato2, Glen Kristiansen3, Gabriele Calaminus4, Christian Vokuhl5, Ivo Leuschner5, Torsten Pietsch1.   

Abstract

Central nervous system germinomas are characterized by a massive immune cell infiltrate. We systematically characterized these immune cells in 28 germinomas by immunophenotyping and image analysis. mRNA expression was analyzed by Nanostring technology and in situ RNA hybridization. Tumor infiltrating lymphocytes (TILs) were composed of 61.8% ± 3.1% (mean ± SE) CD3-positive T cells, including 45.2% ± 3.5% of CD4-positive T-helper cells, 23.4% ± 1.5% of CD8-positive cytotoxic T cells, 5.5% ± 0.9% of FoxP3-positive regulatory T cells, and 11.9% ±1.3% PD-1-positive TILs. B cells accounted for 35.8% ± 2.9% of TILs and plasma cells for 9.3% ± 1.6%. Tumor-associated macrophages consisted of clusters of activated PD-L1-positive macrophages and interspersed anti-inflammatory macrophages expressing CD163. Germinoma cells did not express PD-L1. Expression of genes encoding immune cell markers and cytokines was high and comparable to mRNA levels in lymph node tissue. IFNG and IL10 mRNA was detected in subfractions of TILs and in PD-L1-positive macrophages. Taken together, the strong immune reaction observed in germinomas involves inflammatory as well as various suppressive mechanisms. Expression of PD-1 and PD-L1 and infiltration of cytotoxic T cells are biomarkers predictive of response to anti-PD-1/PD-L1 therapies, constituting a rationale for possible novel treatment approaches.
© 2017 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Adaptive immune response; Germinoma; PD-L1; Tumor associated macrophages; Tumor infiltrating lymphocytes

Mesh:

Substances:

Year:  2018        PMID: 29237087     DOI: 10.1093/jnen/nlx106

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  8 in total

1.  Tumor immune microenvironment is associated with the growth of intracranial germinomas.

Authors:  Masaaki Nishimoto; Kentaro Ohara; Dai Kamamoto; Ryota Tamura; Tomoru Miwa; Kazunari Yoshida; Hikaru Sasaki
Journal:  J Neurooncol       Date:  2019-11-26       Impact factor: 4.130

2.  MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors.

Authors:  Stefan Schönberger; Mahsa Mir Mohseni; Jörg Ellinger; Giao Vu Quynh Tran; Martina Becker; Alexander Claviez; Carl-Friedrich Classen; Barbara Hermes; Pablo Hernáiz Driever; Norbert Jorch; Melchior Lauten; Marcus Mehlitz; Niklas Schäfer; Johanna Scheer-Preiss; Dominik T Schneider; Anja Troeger; Gabriele Calaminus; Dagmar Dilloo
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-16       Impact factor: 4.553

3.  Targeting EpCAM by a Bispecific Trifunctional Antibody Exerts Profound Cytotoxic Efficacy in Germ Cell Tumor Cell Lines.

Authors:  Stefan Schönberger; Daniela Kraft; Daniel Nettersheim; Hubert Schorle; Anna Casati; Rogerio B Craveiro; Mahsa Mir Mohseni; Gabriele Calaminus; Dagmar Dilloo
Journal:  Cancers (Basel)       Date:  2020-05-19       Impact factor: 6.639

4.  Low tumor cell content predicts favorable prognosis in germinoma patients.

Authors:  Hirokazu Takami; Kaishi Satomi; Kohei Fukuoka; Shintaro Fukushima; Yuko Matsushita; Kai Yamasaki; Taishi Nakamura; Shota Tanaka; Akitake Mukasa; Nobuhito Saito; Tomonari Suzuki; Takaaki Yanagisawa; Hideo Nakamura; Kazuhiko Sugiyama; Kaoru Tamura; Taketoshi Maehara; Mitsutoshi Nakada; Masahiro Nonaka; Akio Asai; Kiyotaka Yokogami; Hideo Takeshima; Toshihiko Iuchi; Yonehiro Kanemura; Keiichi Kobayashi; Motoo Nagane; Kazuhiko Kurozumi; Koji Yoshimoto; Masahide Matsuda; Akira Matsumura; Yuichi Hirose; Tsutomu Tokuyama; Toshihiro Kumabe; Yoshitaka Narita; Soichiro Shibui; Yoichi Nakazato; Ryo Nishikawa; Masao Matsutani; Koichi Ichimura
Journal:  Neurooncol Adv       Date:  2021-08-10

Review 5.  Pathogenesis of central nervous system germ cell tumors.

Authors:  Siyuan Liu; Linan Ren; Xue Gao; Mengjin Hao; Guixia Wang
Journal:  Front Oncol       Date:  2022-09-09       Impact factor: 5.738

6.  Gender Related Changes in Gene Expression Induced by Valproic Acid in A Mouse Model of Autism and the Correction by S-adenosyl Methionine. Does It Explain the Gender Differences in Autistic Like Behavior?

Authors:  Liza Weinstein-Fudim; Zivanit Ergaz; Gadi Turgeman; Joseph Yanai; Moshe Szyf; Asher Ornoy
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

Review 7.  Histopathology of Parasellar Neoplasms.

Authors:  Emilija Manojlovic-Gacic; Elham Rostami; Niki Karavitaki; Olivera Casar-Borota
Journal:  Neuroendocrinology       Date:  2020-03-11       Impact factor: 4.914

8.  EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults.

Authors:  Didier Frappaz; Girish Dhall; Matthew J Murray; Stuart Goldman; Cecile Faure Conter; Jeffrey Allen; Rolf Dieter Kortmann; Daphne Haas-Kogen; Giovanni Morana; Jonathan Finlay; James C Nicholson; Ute Bartels; Mark Souweidane; Stefan Schönberger; Alexandre Vasiljevic; Patricia Robertson; Assunta Albanese; Claire Alapetite; Thomas Czech; Chin C Lau; Patrick Wen; David Schiff; Dennis Shaw; Gabriele Calaminus; Eric Bouffet
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 13.029

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.